Area of research
Hematology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Placebo, Osteosarcoma, Surgery, and Ipilimumab.
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung
Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation
A randomized, double-blinded, placebo-controlled, multi-institutional, cross-over, phase II.5 study of saracatinib (AZD0530), a selective Src kinase inhibitor, in patients with recurrent osteosarcoma localized to the lung.